Suzanne D. Conzen

Suzanne D. Conzen is a Professor in the Department of Internal Medicine and Chief of the Division of Hematology and Oncology at UT Southwestern Medical Center. A physician-scientist with dual expertise in clinical oncology and molecular biology, she focuses on glucocorticoid receptor (GR) signaling in breast, prostate, and ovarian cancers.

• Education: Yale School of Medicine (MD), Brown University (BA in Political Science, magna cum laude), London School of Hygiene & Tropical Medicine (MSc)
• Clinical Training: Internal Medicine Residency (Cornell Medical Center), Clinical Fellowship in Hematology/Oncology (Dartmouth-Hitchcock), Research Fellowship in Molecular Oncology (Dartmouth Medical School)

Her research program investigates how GR activation influences cancer progression and therapy resistance, particularly in hormone-driven cancers. She employs advanced imaging techniques like MRI radiomics and magnetic resonance spectroscopy to study tumor biology and microenvironment interactions.

Dr. Conzen's recent work explores targeted therapies using selective GR modulators (SGRMs) to improve treatment efficacy in castration-resistant prostate cancer and ER-negative breast cancer. Her lab also examines how dietary factors (e.g., high-fat diets) impact mammary tumorigenesis.

Scientific Awards:

• Elected to American Society for Clinical Investigation (2006)
• Elected to Association of American Physicians (2020)
• Leadership roles: Senior Editor of Cancer Research, Chair of NIH Cancer Etiology Study Section

She holds multiple National Cancer Institute grants and receives funding from the Breast Cancer Research Foundation.